Intracisternal, but not intrathecal, injection of naloxone inhibits cutaneous itch-related response in mice

31Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

The present study was conducted to determine whether cutaneous itch involves mu-opioid receptors in either of the spinal cord or lower brainstem or in both regions in mice. An intraplantar injection of serotonin hydrochloride (100 nmol/site) induced biting, an itch-related behavior. The behavior was inhibited by subcutaneous (0.3-1 mg/kg) and intracisternal (1-10 nmol/site), but not intrathecal (1-10 nmol/site), injections of naloxone hydrochloride. An intradermal injection of serotonin (100 nmol/site) to the rostral back induced scratching, an itch-related behavior, which was inhibited by subcutaneous (1 mg/kg) and intracisternal (10 nmol/site) injections of naloxone. These results suggest that mu-opioid receptor in the lower brainstem, but not spinal cord, is a site of central pruritogenic action of opioids and is involved in the facilitatory regulation of itch signaling. © 2008 Pharmaceutical Society of Japan.

Cite

CITATION STYLE

APA

Kuraishi, Y., Yageta, Y., Konno, M., Andoh, T., Yamaguchi-Miyamoto, T., & Nojima, H. (2008). Intracisternal, but not intrathecal, injection of naloxone inhibits cutaneous itch-related response in mice. Biological and Pharmaceutical Bulletin, 31(11), 2143–2145. https://doi.org/10.1248/bpb.31.2143

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free